
Curis CRIS
$ 1.17
0.86%
Quarterly report 2025-Q3
added 11-06-2025
Curis P/B Ratio 2011-2025 | CRIS
Annual P/B Ratio Curis
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.21 | 2.83 | 0.0592 | 3.22 | 4.36 | -1.59 | -8.47 | 4.16 | 12.3 | 3.14 | 5.31 | 5.38 | 7.06 | 9.09 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12.3 | -8.47 | 3.19 |
P/B Ratio of other stocks in the Biotechnology industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
4.2 | $ 4.85 | 2.87 % | $ 805 M | ||
|
Aclaris Therapeutics
ACRS
|
0.979 | $ 3.21 | -1.23 % | $ 248 M | ||
|
AlloVir
ALVR
|
0.432 | - | 4.14 % | $ 49.1 M | ||
|
Aptevo Therapeutics
APVO
|
0.187 | $ 1.06 | -6.64 % | $ 293 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | ||
|
Ascendis Pharma A/S
ASND
|
8.34 | $ 215.41 | -2.27 % | $ 5 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M | ||
|
Alterity Therapeutics Limited
ATHE
|
125 | $ 3.15 | -3.85 % | $ 7.58 B | ||
|
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | ||
|
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - | ||
|
BioVie
BIVI
|
0.128 | $ 1.43 | -1.39 % | $ 2.11 M | ||
|
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
51.9 | - | -15.15 % | $ 60.3 M | ||
|
BioNTech SE
BNTX
|
5.29 | $ 94.02 | -0.84 % | $ 27.2 B | ||
|
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | ||
|
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | ||
|
Alpine Immune Sciences
ALPN
|
1.5 | - | - | $ 2.17 B | ||
|
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 26.2 | 3.68 % | $ 1.27 B | ||
|
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | ||
|
Anika Therapeutics
ANIK
|
1.38 | $ 9.59 | 0.31 % | $ 141 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
32 | $ 0.27 | -6.08 % | $ 588 M | ||
|
Arena Pharmaceuticals
ARNA
|
7.2 | - | -6.81 % | $ 3.04 B | ||
|
Athersys
ATHX
|
11.6 | - | 3.77 % | $ 22.4 M | ||
|
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M | ||
|
Catalyst Biosciences
CBIO
|
0.428 | $ 13.48 | -4.36 % | $ 887 M | ||
|
Avenue Therapeutics
ATXI
|
0.293 | - | -52.27 % | $ 4.45 M | ||
|
AVROBIO
AVRO
|
0.594 | - | 1083.1 % | $ 745 M | ||
|
Axon Enterprise
AXON
|
17.1 | $ 549.1 | -2.69 % | $ 41.6 B | ||
|
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
0.127 | $ 2.4 | 4.34 % | $ 15.1 M | ||
|
AstraZeneca PLC
AZN
|
2.07 | $ 91.04 | 1.35 % | $ 96.9 B | ||
|
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
0.982 | - | -5.38 % | $ 6.06 M | ||
|
Burford Capital Limited
BUR
|
1.26 | $ 8.87 | -1.55 % | $ 1.45 B | ||
|
BeiGene, Ltd.
BGNE
|
75.9 | - | 0.49 % | $ 251 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-12.6 | $ 11.23 | -2.69 % | $ 726 M | ||
|
Biogen
BIIB
|
1.16 | $ 174.94 | 0.48 % | $ 25.5 B | ||
|
Abeona Therapeutics
ABEO
|
10.1 | $ 5.07 | -5.5 % | $ 108 M | ||
|
Celldex Therapeutics
CLDX
|
0.00176 | $ 27.11 | -1.47 % | $ 1.75 M | ||
|
ADiTx Therapeutics
ADTX
|
0.00714 | $ 1.66 | -25.84 % | $ 21.9 K | ||
|
Cellectar Biosciences
CLRB
|
-3.23 | $ 3.36 | -7.32 % | $ 41.1 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
0.415 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
0.824 | - | -7.31 % | $ 87 M | ||
|
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | ||
|
Завод ДИОД
DIOD
|
0.549 | - | - | - | ||
|
Фармсинтез
LIFE
|
1.97 | - | - | - |